Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer

MLA

Hannah J. Gregson, et al. “Monocarboxylate Transporter 1 (MCT1) Is an Independent Prognostic Biomarker in Endometrial Cancer.” BMC Clinical Pathology, vol. 17, no. 1, Dec. 2017, pp. 1–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2988b7c7ec7d61abc52b001e69a8d9ac&authtype=sso&custid=ns315887.

APA

Hannah J. Gregson, Kay Marshall, Stephen A Roberts, Sarah Kitson, Vanitha N Sivalingam, Kaye J. Williams, Amy L. Chadwick, James Bolton, Ayse Latif, Emma J Crosbie, Rhona J McVey, & Ian J. Stratford. (2017). Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer. BMC Clinical Pathology, 17(1), 1–10.

Chicago

Hannah J. Gregson, Kay Marshall, Stephen A Roberts, Sarah Kitson, Vanitha N Sivalingam, Kaye J. Williams, Amy L. Chadwick, et al. 2017. “Monocarboxylate Transporter 1 (MCT1) Is an Independent Prognostic Biomarker in Endometrial Cancer.” BMC Clinical Pathology 17 (1): 1–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2988b7c7ec7d61abc52b001e69a8d9ac&authtype=sso&custid=ns315887.